The Future of Medtech

Download PDF, 551 KB

Healthcare August 2013

The Future of Medtech

Applying the Power of Innovation

In the medtech industry new products stand for a large share of profits. The Arthur D. Little recent global Innovation Excellence study identified that innovation systems impact significantly the profitability and the time-to-market for new product development thus demanding high performance in this domain.  [...]

New GDP guidelines: looking beyond

Download PDF, 172 KB

Healthcare May 2013

New GDP guidelines: looking beyond

Regulatory changes of Good Distribution Practice (GDP) of Medicinal Products increase complexity

In 2013, the EU-guidelines on GDP of Medicinal Products for Human Use have been augmented: Now for example, the required storage conditions of pharmaceuticals are to be maintained during transportation. In addition, new requirements apply concerning cleanliness and security of any intermediate storage facility. Although increasing complexity these specifications create space for opportunities such as differentiation or benefit from cost advantage over competition. [...]

Launch excellence for new medicines

Download PDF, 825 KB

Healthcare April 2013

Launch excellence for new medicines

Global challenges require new approach for market entry

After years of low productivity, R&D in leading pharmaceutical and biotech companies is starting to deliver on its promises and the number of New Molecular Entities (NMEs) approved by the US FDA has leveled out. Once approval has been gained there needs to be a launch. However, complexity of global market access has substantially increased. In this viewpoint, Arthur D. Little assesses the key success factors for launch excellence in times of global market access challenge. [...]

Capturing Value in the mHealth Oasis

Download PDF, 599 KB

Healthcare, TIME March 2011

Capturing Value in the mHealth Oasis

An Opportunity for Mobile Network Operators

mHealth has been hailed as the next major development for mobile networks operators (MNOs), but could it be just wishful thinking from a sector desperately seeking additional revenues to offset margin erosion? While few commercial offers currently exist, mHealth is firmly on the agenda for many MNOs. In this viewpoint, Arthur D. Little assesses the key success factors that lay the foundations for operators to successfully navigate the mHealth minefield. [...]

| |Bookmark Arthur D. Little